Biogen halts development of Gosuranemab, therapy for rare brain disease Medical Dialogues Bureau15 Dec 2019 8:58 AM ISTThe therapy, Gosuranemab, failed to hit statistical significance in its main goal and did not demonstrate effectiveness on key secondary goals when...
Sanofi to reduce investment in Onduo, USD 500 million joint venture with Verily Farhat Nasim14 Dec 2019 1:55 PM ISTHowever, after several years of partnership, the two parties do not seem to align well as Sanofi recently withdrew from the Joint Venture, Onduo...
Sun Pharma Halol facility gets 8 USFDA observations post GMP inspection Farhat Nasim14 Dec 2019 12:50 PM ISTThe U.S Food and Drug Administration (USFDA) conducted a Good Manufacturing Practices (GMP) inspection of the company's Halol facility (Gujarat,...
Patent Infringement: Bristol-Myers wins case against Gilead; awarded USD 752 million in damages Medical Dialogues Bureau14 Dec 2019 9:35 AM ISTA jury in Los Angeles awarded the damages after finding that Yescarta, a treatment sold by Gilead's Kite Pharma unit, infringed on a patent...
Roche Tecentriq cocktail shows progression-free survival in melanoma patient Medical Dialogues Bureau14 Dec 2019 9:20 AM ISTRoche has an extensive clinical trial development programme for Tecentriq, with more than 50 studies for use in fighting lung, kidney, skin, breast,...
Sanofi, Biocorp enter partnership to fit SoloStar insulin pens with Mallya technology Medical Dialogues Bureau14 Dec 2019 9:15 AM ISTThis long-term agreement is the first decision resulting from exclusive negotiations initiated in July 2019. Sanofi and Biocorp are thus fulfilling...
Biocon, Equillium expand license agreement for plaque psoriasis drug Itolizumab Farhat Nasim13 Dec 2019 3:37 PM ISTEquillium had originally secured exclusive rights to develop and commercialize Biocon Ltd’s novel biologic, Itolizumab, for the U.S. and Canada...
Hikal Gujarat facility gets EIR from USFDA Farhat Nasim13 Dec 2019 3:07 PM ISTThe pharmaceutical manufacturing facility at Panoli in Gujarat was recently inspected by the US Food and Drug Administration (USFDA) in compliance...
Aurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from US Medical Dialogues Bureau13 Dec 2019 9:30 AM ISTAurobindo Pharma arm AuroMedics Pharma LLC is recalling 59,500 vials of the injection on account of "Discoloration; hazy solution found in one vial...
Sarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nod Medical Dialogues Bureau13 Dec 2019 9:30 AM IST Sarepta Therapeutics said the new treatment Vyondys 53 is priced at parity to its first DMD drug, Exondys 51, which is priced at about $300,000 per...
Cipla associate Avenue Therapeutics files US application for IV tramadol Farhat Nasim12 Dec 2019 3:30 PM ISTNew Delhi: Cipla Ltd's associate company, Avenue Therapeutics, Inc. ("Avenue"), a company focused on the development of intravenous ("IV") tramadol...
Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production Medical Dialogues Bureau12 Dec 2019 9:30 AM ISTAs a first step, the company has signed up a deal with a Chinese firm for procuring high-speed machines which would enable Eurolife manufactures the...
